Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Learn which fund family offers the best Sharpe ratio indices and why it matters for risk-adjusted performance. Compare funds to identify strong performers.
28,055 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
Celsius Holdings delivered a blowout Q4 and full-year results, sending shares higher as revenue accelerates and margi...
Nvidia unveils a $2 billion investment in Lumentum, pairing strategic scale with a fast-growing demand for AI-grade o...
Duolingo stock fell February as investors reeled from a shaky user metric and rising AI disruption concerns. This art...
Kalshi and Polymarket are reportedly exploring rounds that could push each platform toward $20 billion valuations, up...
Amazon is reviewing AI-driven outages after a wave of disruptions, including Gen-AI coding incidents. Elon Musk react...
As autonomous driving heats up, two stocks stand out as potential multibagger candidates by 2030. This article breaks...
The Federal Reserve decided to keep rates unchanged, citing resilient growth and persistent price pressures. Geopolit...
Markets brace for a year where prices rise while growth falters. This report explains why stagflation: word year 2026...
Gold prices fell as headlines about US-Iran tensions eased, while Bitcoin and other risk assets climbed, signaling a ...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...